28th consecutive quarter of year-over-year net sales growth; year-to-date 2026 net sales up 25.8%
"Lifeway delivered another record breaking quarter with net sales of
Third Quarter 2026 Highlights
Net Sales :$67.8 million , the highest quarterly net sales in Company history, up 18.6% year-over-year, primarily driven by higher volumes of the Company's branded drinkable kefir.- Gross Profit Margin: 18.0%, compared to 28.7% in the prior-year period, primarily reflecting elevated input costs including milk, resin-based packaging, ingredients, and transportation costs.
- Selling, general and administrative expenses were 16.2% of net sales, compared to 19.6% last year, reflecting continued investment in marketing and brand awareness.
- Net Income:
$0.3 million , or$0.02 per basic and diluted common share, compared to net income of$3.5 million , or$0.23 per basic and diluted common share, in the prior-year period.
Year-to-Date 2026 Highlights
Net Sales :$197.7 million , up 25.8% year-over-year.- Gross Profit Margin: 21.5%, compared to 27.3% in the prior-year period.
- Selling, general and administrative expenses were 17.2% of net sales, compared to 19.1% last year.
- Net Income:
$5.1 million , or$0.33 per basic and diluted common share, compared to net income of$11.3 million , or$0.75 per basic and$0.74 per diluted common share, in the prior-year period.
Historic Growth Record
- 28 consecutive quarters of year-over-year net sales growth, reflecting seven years of uninterrupted quarterly growth.
- Four consecutive years of record annual net sales from 2022 through 2025, increasing from
$141.6 million to$212.5 million – a cumulative increase of 50.1%. - Year-to-date net sales equaled approximately 93% of full-year 2025 net sales, with the Company well on pace to set a record high in annual net sales in 2026, far exceeding the high-bar set in 2025.
Industry Recognition
In October, Lifeway was named to Fortune's 2026 list of the 100 Fastest-Growing Companies, ranking No. 45, reflecting the Company's sustained, volume-led growth and the strength of consumer demand for kefir and other cultured dairy products. This inclusion places Lifeway among an elite group of publicly traded companies that have delivered notably strong financial performance. This follows the induction of President and Chief Executive Officer
Conference Call and Webcast
A live conference call and Q&A session with management discussing these results with additional comments and details will be made available through the "Investor Relations" section of the Company's website at https://lifewaykefir.com/webinars-reports/ at
About
Forward-Looking Statements
This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, unaudited estimated net sales. These statements use words, and variations of words, such as "anticipate," "plan," "project," "estimate," "potential," "forecast," "will," "continue," "future," "increase," "believe," "outlook," "expect," and "predict." You are cautioned not to rely on these forward-looking statements. These forward-looking statements are made as of the date of this press release, are based on current expectations of future events and thus are inherently subject to a number of risks and uncertainties, many of which involve factors or circumstances beyond Lifeway's control. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from Lifeway's expectations and projections. These risks, uncertainties, and other factors include: price competition; the decisions of customers or consumers; the actions of competitors; changes in the pricing of commodities; the effects of government regulation; possible delays in the introduction of new products; and customer acceptance of products and services. A further list and description of these risks, uncertainties, and other factors can be found in Lifeway's Annual Report on Form 10-K for the fiscal year ended
Vice President of Communications,
Email: derekm@lifeway.net
General inquiries:
Phone: 847-967-1010
Email: info@lifeway.net
| | ||||||||
| Unaudited Consolidated Balance Sheets | ||||||||
| | ||||||||
| (In thousands) | ||||||||
| | ||||||||
| | | | | | | | ||
| | | 2026 | | | 2025 | | ||
| | | (Unaudited) | | | | | ||
| Current assets | | | | | | | | |
| Cash and cash equivalents | | $ | 6,975 | | | $ | 5,571 | |
| Accounts receivable, net of allowance for credit losses and discounts & allowances of | | | 22,353 | | | | 16,643 | |
| Inventories, net | | | 13,594 | | | | 11,890 | |
| Prepaid expenses and other current assets | | | 2,470 | | | | 2,627 | |
| Refundable income taxes | | | 636 | | | | 325 | |
| Total current assets | | | 46,028 | | | | 37,056 | |
| | | | | | | | | |
| Property, plant and equipment, net | | | 67,393 | | | | 48,282 | |
| Operating lease right-of-use asset | | | 504 | | | | 465 | |
| | | | 11,704 | | | | 11,704 | |
| Intangible assets, net | | | 5,413 | | | | 5,818 | |
| Other assets | | | 1,629 | | | | 2,285 | |
| Total assets | | $ | 132,671 | | | $ | 105,610 | |
| | | | | | | | | |
| Current liabilities | | | | | | | | |
| Accounts payable | | $ | 12,739 | | | $ | 11,008 | |
| Accrued expenses | | | 6,363 | | | | 5,413 | |
| Accrued income taxes | | | 716 | | | | 218 | |
| Total current liabilities | | | 19,818 | | | | 16,639 | |
| | | | | | | | | |
| Line of credit | | | 11,950 | | | | – | |
| Note payable | | | 12,032 | | | | – | |
| Operating lease liabilities | | | 370 | | | | 360 | |
| Deferred income taxes, net | | | 2,792 | | | | 2,792 | |
| Other long-term liabilities | | | 251 | | | | – | |
| Total liabilities | | | 47,213 | | | | 19,791 | |
| | | | | | | | | |
| Commitments and contingencies (Note 9) | | | – | | | | – | |
| | | | | | | | | |
| Stockholders' equity | | | | | | | | |
| Preferred stock, no par value; 2,500 shares authorized; none issued | | | – | | | | – | |
| Common stock, no par value; 40,000 shares authorized; 17,274 shares issued; 15,108 | | | 6,509 | | | | 6,509 | |
| | | | (17,194) | | | | (13,214) | |
| Paid-in capital | | | 2,401 | | | | 3,843 | |
| Retained earnings | | | 93,742 | | | | 88,681 | |
| Total stockholders' equity | | | 85,458 | | | | 85,819 | |
| | | | | | | | | |
| Total liabilities and stockholders' equity | | $ | 132,671 | | | $ | 105,610 | |
| | ||||||||||||||||
| Consolidated Statements of Operations | ||||||||||||||||
| For the three and nine months ended | ||||||||||||||||
| (Unaudited) | ||||||||||||||||
| (In thousands, except per share data) | ||||||||||||||||
| | ||||||||||||||||
| | | Three Months Ended | | | Nine Months Ended | | ||||||||||
| | | 2026 | | | 2025 | | | 2026 | | | 2025 | | ||||
| | | | | | | | | | | | | | ||||
| Net sales | | $ | 67,797 | | | $ | 57,143 | | | $ | 197,702 | | | $ | 157,135 | |
| | | | | | | | | | | | | | | | | |
| Cost of goods sold | | | 54,599 | | | | 39,821 | | | | 152,199 | | | | 111,744 | |
| Depreciation expense | | | 1,034 | | | | 914 | | | | 2,962 | | | | 2,548 | |
| Total cost of goods sold | | | 55,633 | | | | 40,735 | | | | 155,161 | | | | 114,292 | |
| | | | | | | | | | | | | | | | | |
| Gross profit | | | 12,164 | | | | 16,408 | | | | 42,541 | | | | 42,843 | |
| | | | | | | | | | | | | | | | | |
| Selling expense | | | 6,434 | | | | 5,047 | | | | 20,256 | | | | 14,463 | |
| General and administrative expense | | | 4,510 | | | | 6,186 | | | | 13,870 | | | | 15,566 | |
| Amortization expense | | | 135 | | | | 135 | | | | 405 | | | | 405 | |
| Total operating expenses | | | 11,079 | | | | 11,368 | | | | 34,531 | | | | 30,434 | |
| | | | | | | | | | | | | | | | | |
| Income from operations | | | 1,085 | | | | 5,040 | | | | 8,010 | | | | 12,409 | |
| | | | | | | | | | | | | | | | | |
| Other income (expense): | | | | | | | | | | | | | | | | |
| Interest expense | | | (340) | | | | (21) | | | | (623) | | | | (56) | |
| Fair Value Loss on investments | | | – | | | | – | | | | – | | | | (20) | |
| Gain on sale of investments | | | – | | | | – | | | | – | | | | 3,407 | |
| Other income (expense), net | | | 20 | | | | 73 | | | | 42 | | | | 229 | |
| Total other income (expense) | | | (320) | | | | 52 | | | | (581) | | | | 3,560 | |
| | | | | | | | | | | | | | | | | |
| Income before provision for income taxes | | | 765 | | | | 5,092 | | | | 7,429 | | | | 15,969 | |
| | | | | | | | | | | | | | | | | |
| Provision for income taxes | | | 505 | | | | 1,563 | | | | 2,368 | | | | 4,651 | |
| | | | | | | | | | | | | | | | | |
| Net income | | $ | 260 | | | $ | 3,529 | | | $ | 5,061 | | | $ | 11,318 | |
| | | | | | | | | | | | | | | | | |
| Net earnings per common share: | | | | | | | | | | | | | | | | |
| Basic | | $ | 0.02 | | | $ | 0.23 | | | $ | 0.33 | | | $ | 0.75 | |
| Diluted | | $ | 0.02 | | | $ | 0.23 | | | $ | 0.33 | | | $ | 0.74 | |
| | | | | | | | | | | | | | | | | |
| Weighted average common shares outstanding: | | | | | | | | | | | | | | | | |
| Basic | | | 15,107 | | | | 15,229 | | | | 15,174 | | | | 15,190 | |
| Diluted | | | 15,253 | | | | 15,422 | | | | 15,314 | | | | 15,381 | |
| | ||||||||
| Consolidated Statements of Cash Flows | ||||||||
| (Unaudited) | ||||||||
| (In thousands) | ||||||||
| | ||||||||
| | | Nine months ended | | |||||
| | | 2026 | | | 2025 | | ||
| Cash flows from operating activities: | | | | | | | | |
| Net income | | $ | 5,061 | | | $ | 11,318 | |
| Adjustments to reconcile net income to operating cash flow: | | | | | | | | |
| Depreciation and amortization | | | 3,367 | | | | 2,953 | |
| Stock-based compensation | | | 1,708 | | | | 1,466 | |
| Non-cash interest expense | | | 16 | | | | 14 | |
| Bad debt expense | | | 87 | | | | – | |
| Gain on sale of equipment | | | (17) | | | | (115) | |
| Gain on sale of investments | | | – | | | | (3,407) | |
| Fair value loss on investment | | | – | | | | 20 | |
| (Increase) decrease in operating assets: | | | | | | | | |
| Accounts receivable | | | (5,797) | | | | (1,997) | |
| Inventories | | | (1,704) | | | | (2,378) | |
| Prepaid expenses and other current assets | | | 354 | | | | 123 | |
| Refundable income taxes | | | (311) | | | | 497 | |
| Increase (decrease) in operating liabilities: | | | | | | | | |
| Accounts payable | | | 2,413 | | | | 3,330 | |
| Accrued expenses | | | (988) | | | | (1,143) | |
| Accrued income taxes | | | 497 | | | | – | |
| Other long-term liabilities | | | 251 | | | | – | |
| Net cash provided by operating activities | | | 4,937 | | | | 10,681 | |
| | | | | | | | | |
| Cash flows from investing activities: | | | | | | | | |
| Purchases of property and equipment | | | (22,757) | | | | (9,675) | |
| Proceeds from sale of equipment | | | 433 | | | | 115 | |
| Proceeds from sale of investments | | | – | | | | 5,206 | |
| Net cash (used in) provided by investing activities | | | (22,324) | | | | (4,354) | |
| | | | | | | | | |
| Cash flows from financing activities: | | | | | | | | |
| Purchase of treasury stock | | | (4,937) | | | | – | |
| Borrowings under line of credit | | | 25,000 | | | | – | |
| Repayments under line of credit | | | (13,000) | | | | – | |
| Proceeds from note payable | | | 12,032 | | | | – | |
| Payment of deferred financing costs | | | (21) | | | | (65) | |
| Equity award settled in cash | | | (283) | | | | – | |
| Net cash provided by (used in) financing activities | | | 18,791 | | | | (65) | |
| | | | | | | | | |
| Net increase in cash and cash equivalents | | | 1,404 | | | | 6,262 | |
| | | | | | | | | |
| Cash and cash equivalents at the beginning of the period | | | 5,571 | | | | 16,728 | |
| | | | | | | | | |
| Cash and cash equivalents at the end of the period | | $ | 6,975 | | | $ | 22,990 | |
| | | | | | | | | |
| Supplemental cash flow information: | | | | | | | | |
| Cash paid for income taxes, net of (refunds) | | $ | 2,181 | | | $ | 4,154 | |
| Cash paid for interest | | $ | 511 | | | $ | 42 | |
| | | | | | | | | |
| Non-cash investing activities | | | | | | | | |
| Accrued purchase of property and equipment | | $ | 93 | | | $ | 3,875 | |
| Right-of-use assets obtained in exchange for lease obligations | | $ | 135 | | | $ | 293 | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lifeway-foods-reports-record-high-quarterly-net-sales-extends-kefir-category-leadership-in-third-quarter-2026-302938328.html
SOURCE